Page 21 - Read Online
P. 21

Magnifico et al. Rare Dis Orphan Drugs J 2023;2:16  https://dx.doi.org/10.20517/rdodj.2023.17  Page 15 of 15

               16.      Loeber A, Bernstein MJ, Nieminen M. Implementing responsible research and innovation: from new public management to new public
                   governance. In: Blok V, editor. Putting Responsible Research and Innovation into Practice. Cham: Springer International Publishing;
                   2023. pp. 211-28.  DOI
               17.      Responsible research and innovation: Europe’s ability to respond to societal challenges Available from: https://data.europa.eu/doi/10.
                   2777/11739 [Last accessed on 24 Aug 2023].
               18.      European commission. Open innovation, open science, open to the world. Available from: http://europa.eu/rapid/press-release_
                   SPEECH-15-5243_en.htm [Last accessed on 24 Aug 2023].
                              R
               19.      HTA core model  version 3.0. Available from: https://www.eunethta.eu/hta-core-model/  [Last accessed on 29 Aug 2023].
               20.      HTA core model version 3.0. Available from: https://www.eunethta.eu/wp-content/uploads/2018/03/HTACoreModel3.0-1.pdf [Last
                   accessed on 29 Aug 2023].
               21.      Downie L, Halliday J, Lewis S, Amor DJ. Principles of genomic newborn screening programs: a systematic review. JAMA Netw Open
                   2021;4:e2114336.  DOI  PubMed  PMC
               22.      Souche E, Beltran S, Brosens E, et al. Recommendations for whole genome sequencing in diagnostics for rare diseases. Eur J Hum
                   Genet 2022;30:1017-21.  DOI  PubMed  PMC
               23.      Hendricks-Sturrup RM, Lu CY. When should genomic and exome sequencing be implemented in newborns? Genet Med 2020;22:809-
                   10.  DOI
               24.      van El CG, Cornel MC, Borry P, et al; ESHG Public and Professional Policy Committee. Whole-genome sequencing in health care:
                   recommendations of the European society of human genetics. Eur J Hum Genet 2013;21:580-4.  DOI  PubMed  PMC
               25.      Morava E, Baumgartner M, Patterson M, Peters V, Rahman S. Newborn screening: to WES or not to WES, that is the question. J
                   Inherit Metab Dis 2020;43:904-5.  DOI  PubMed
               26.      Veldman A, Kiewiet MBG, Heiner-Fokkema MR, et al. Towards next-generation sequencing (NGS)-based newborn screening: a
                   technical study to prepare for the challenges ahead. Int J Neonatal Screen 2022;8:17.  DOI  PubMed  PMC
               27.      Roman TS, Crowley SB, Roche MI, et al. Genomic sequencing for newborn screening: results of the NC NEXUS project. Am J Hum
                   Genet 2020;107:596-611.  DOI  PubMed  PMC
               28.      Ceyhan-Birsoy O, Murry JB, Machini K, et al; BabySeq Project Team. Interpretation of genomic sequencing results in healthy and ill
                   newborns: results from the BabySeq project. Am J Hum Genet 2019;104:76-93.  DOI  PubMed  PMC
               29.      Wojcik MH, Zhang T, Ceyhan-Birsoy O, et al; BabySeq Project Team. Discordant results between conventional newborn screening
                   and genomic sequencing in the BabySeq Project. Genet Med 2021;23:1372-5.  DOI  PubMed  PMC
               30.      Genetti CA, Schwartz TS, Robinson JO, et al; BabySeq Project Team. Parental interest in genomic sequencing of newborns:
                   enrollment experience from the BabySeq project. Genet Med 2019;21:622-30.  DOI  PubMed  PMC
               31.      Lewis MA, Paquin RS, Roche MI, et al. Supporting parental decisions about genomic sequencing for newborn screening: the NC
                   NEXUS decision Aid. Pediatrics 2016;137 Suppl 1:S16-23.  DOI  PubMed  PMC
               32.      Ulm E, Feero WG, Dineen R, Charrow J, Wicklund C. Genetics professionals' opinions of whole-genome sequencing in the newborn
                   period. J Genet Couns 2015;24:452-63.  DOI  PubMed
               33.      Bombard Y, Miller FA, Hayeems RZ, et al. Public views on participating in newborn screening using genome sequencing. Eur J Hum
                   Genet 2014;22:1248-54.  DOI  PubMed  PMC
               34.      Johnston J, Lantos JD, Goldenberg A, Chen F, Parens E, Koenig BA; members of the NSIGHT Ethics and Policy Advisory Board.
                   Sequencing newborns: a call for nuanced use of genomic technologies. Hastings Cent Rep 2018;48 Suppl 2:S2-6.  DOI  PubMed  PMC
               35.      Reinstein E. Challenges of using next generation sequencing in newborn screening. Genet Res 2015;97:e21.  DOI  PubMed  PMC
               36.      Grob R, Roberts S, Timmermans S. Families' experiences with newborn screening: a critical source of evidence. Hastings Cent Rep
                   2018;48 Suppl 2:S29-31.  DOI  PubMed
               37.      Joseph G, Chen F, Harris-Wai J, Puck JM, Young C, Koenig BA. Parental views on expanded newborn screening using whole-genome
                   sequencing. Pediatrics 2016;137 Suppl 1:S36-46.  DOI  PubMed  PMC
               38.      King JS, Smith ME. Whole-genome screening of newborns? Pediatrics 2016;137 Suppl 1:S8-15.  DOI  PubMed  PMC
               39.      Friedman JM, Cornel MC, Goldenberg AJ, Lister KJ, Sénécal K, Vears DF; Global Alliance for Genomics and Health Regulatory and
                   Ethics Working Group Paediatric Task Team. Genomic newborn screening: public health policy considerations and recommendations.
                   BMC Med Genomics 2017;10:9.  DOI  PubMed  PMC
               40.      Morrison A, Dowler J. Newborn screening for disorders and abnormalities in Canada. Available from: https://www.cadth.ca/sites/
                   default/files/pdf/Newborn_Screening_es-26_e.pdf [Last accessed on 24 Aug 2023].
               41.      Goldenberg AJ, Sharp RR. The ethical hazards and programmatic challenges of genomic newborn screening. JAMA 2012;307:461-2.
                   DOI  PubMed  PMC
               42.      Timmermans S, Buchbinder M. Patients-in-waiting: living between sickness and health in the genomics era. J Health Soc Behav
                   2010;51:408-23.  DOI  PubMed
               43.      COMMITTEE ON BIOETHICS, COMMITTEE ON GENETICS, AND, AMERICAN COLLEGE OF MEDICAL GENETICS AND,
                   GENOMICS SOCIAL, ETHICAL, LEGAL ISSUES COMMITTEE. Ethical and policy issues in genetic testing and screening of
                   children. Pediatrics 2013;131:620-2.  DOI  PubMed
               44.      Alarcón Garavito GA, Moniz T, Déom N, Redin F, Pichini A, Vindrola-Padros C. The implementation of large-scale genomic
                   screening or diagnostic programmes: a rapid evidence review. Eur J Hum Genet 2023;31:282-95.  DOI  PubMed  PMC
   16   17   18   19   20   21   22   23   24   25   26